BACKGROUND: How weight change affects the metabolic syndrome (MS) and its parameters is unknown, particularly, in a leaner European population such as the French prospective D.E.S.I.R. cohort. METHODS: In 3770 D.E.S.I.R. participants (sex ratio=1) averaging 47.5 years (range 30-64), with measured weight and MS parameters at baseline (D0) and at 6 year follow-up (D6), we assessed this relationship across five weight-change classes, using stable weight as the referent group (-2 to +2 kg). We used analysis-of-covariance to assess changes in each MS parameter and logistic regression to assess incident MS, according to the National Cholesterol Education Program (NCEP). We also assessed weight-change effect on MS status between D0 and D6. RESULTS: At D0, average weight was 68.4 kg (SD 12.3); BMI was 24.8 kg/m2 (SD 3.5). From D0-D6, the cohort gained a mean 2.1 kg (median 2.0; SD 4.4). After adjustment for age and D0 weight, there was a strong linear relationship with weight change and worsening of the following MS parameters at D6: fasting insulin, waist girth, fasting glucose, fasting triglycerides, HDL cholesterol, and systolic and diastolic blood pressure (P<0.0001). After age adjustment, for every kilogram gained over 6 years, risk of developing the NCEP Syndrome increased 22% (OR 1.22; 95% CI 1.18-1.25). NCEP-MS was incident in 3% of those with stable weight compared with 21% among those gaining >9 kg; 10% of those who lost >2 kg reverted to non-NCEP-MS. CONCLUSIONS: All continuous MS measures are linearly related to weight change, and MS can resolve with modest weight loss, underscoring the importance of maintaining lifelong normal weight.
BACKGROUND: How weight change affects the metabolic syndrome (MS) and its parameters is unknown, particularly, in a leaner European population such as the French prospective D.E.S.I.R. cohort. METHODS: In 3770 D.E.S.I.R. participants (sex ratio=1) averaging 47.5 years (range 30-64), with measured weight and MS parameters at baseline (D0) and at 6 year follow-up (D6), we assessed this relationship across five weight-change classes, using stable weight as the referent group (-2 to +2 kg). We used analysis-of-covariance to assess changes in each MS parameter and logistic regression to assess incident MS, according to the National Cholesterol Education Program (NCEP). We also assessed weight-change effect on MS status between D0 and D6. RESULTS: At D0, average weight was 68.4 kg (SD 12.3); BMI was 24.8 kg/m2 (SD 3.5). From D0-D6, the cohort gained a mean 2.1 kg (median 2.0; SD 4.4). After adjustment for age and D0 weight, there was a strong linear relationship with weight change and worsening of the following MS parameters at D6: fasting insulin, waist girth, fasting glucose, fasting triglycerides, HDL cholesterol, and systolic and diastolic blood pressure (P<0.0001). After age adjustment, for every kilogram gained over 6 years, risk of developing the NCEP Syndrome increased 22% (OR 1.22; 95% CI 1.18-1.25). NCEP-MS was incident in 3% of those with stable weight compared with 21% among those gaining >9 kg; 10% of those who lost >2 kg reverted to non-NCEP-MS. CONCLUSIONS: All continuous MS measures are linearly related to weight change, and MS can resolve with modest weight loss, underscoring the importance of maintaining lifelong normal weight.
Authors: M-F Rolland-Cachera; K Castetbon; N Arnault; F Bellisle; M-C Romano; Y Lehingue; M-L Frelut; S Hercberg Journal: Int J Obes Relat Metab Disord Date: 2002-12
Authors: K Borch-Johnsen; S Colagiuri; B Balkau; C Glümer; B Carstensen; A Ramachandran; Y Dong; W Gao Journal: Diabetologia Date: 2004-07-24 Impact factor: 10.122
Authors: M Haftenberger; P H Lahmann; S Panico; C A Gonzalez; J C Seidell; H Boeing; M C Giurdanella; V Krogh; H B Bueno-de-Mesquita; P H M Peeters; G Skeie; A Hjartåker; M Rodriguez; J R Quirós; G Berglund; U Janlert; K T Khaw; E A Spencer; K Overvad; A Tjønneland; F Clavel-Chapelon; B Tehard; A B Miller; K Klipstein-Grobusch; V Benetou; G Kiriazi; E Riboli; N Slimani Journal: Public Health Nutr Date: 2002-12 Impact factor: 4.022
Authors: Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel Journal: Endocr Rev Date: 2008-10-29 Impact factor: 19.871
Authors: Ellen Perkins; Susan K Murphy; Amy P Murtha; Joellen Schildkraut; Randy L Jirtle; Wendy Demark-Wahnefried; Michele R Forman; Joanne Kurtzberg; Francine Overcash; Zhiqing Huang; Cathrine Hoyo Journal: J Pediatr Date: 2012-02-17 Impact factor: 4.406
Authors: F Zaribaf; E Falahi; F Barak; M Heidari; A H Keshteli; A Yazdannik; A Esmaillzadeh Journal: Eur J Clin Nutr Date: 2014-02-19 Impact factor: 4.016
Authors: Martin K Rutter; Lisa M Sullivan; Caroline S Fox; Peter W F Wilson; David M Nathan; Ramachandran S Vasan; Ralph B D'Agostino; James B Meigs Journal: Metab Syndr Relat Disord Date: 2014-07-09 Impact factor: 1.894